Abstract
AbstractBackgroundDespite the importance of the amyloid‐precursor protein (APP) to Alzheimer’s Disease pathophysiology and therapy, and notable pan‐cellular and synaptic abundance, the physiological function of APP and its homologues remains to be fully elucidated in‐vivo. Here, we interrogated how the APP family regulates neuronal cell function and long‐range neural circuit dynamics in the intact brain.MethodAPPflox/flox/APLP2flox /flox/APLP1−/− mice were crossed with NexCre mice expressing Cre prenatally from ∼E12.5 in postmitotic neuronal precursor cells of the cortex and hippocampus, producing a conditional triple knockout model (cTKO) of the APP family in excitatory forebrain neurons that is associated with pronounced behavioral deficits (Steubler et al., 2021, EMBO Journal). Neuronal function at the single cell/unit and circuit‐level was characterised using in‐vivo two‐photon and mesoscopic calcium imaging, and bilateral Neuropixels recordings in awake and anesthetised mice.ResultcTKO mice exhibited pronounced suppression in spike timing variability and dynamic excitability in visual cortex and hippocampus CA1 relative to controls, with a marked inter‐hemispheric decoherence of oscillatory activity (including low‐frequency and sleep‐associated slow waves) and dysfunctional intrahemispheric propagation of neuronal activity. Further, cTKO mice also displayed behavioural abnormalities in open field tests relative to controls which was linked to functional deficits. High‐resolution synaptic imaging revealed a significant reduction in the number of synapses containing the NMDA receptor subunit GluN1 in cTKO mice versus controls, with partial NMDA receptor agonism (d‐cycloserine, 30mg/kg, i.p.) ameliorating cellular and circuit‐level impairments as well as behavioral impairments.ConclusionThese findings provide novel in‐vivo evidence for an essential role of APP in regulating synaptic function via an effect on NMDA receptors, that elucidate the physiological role of this preeminent protein family and have important implications for disease and therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.